Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma. - Wikidata - awgldk - TriplyDB

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

http://www.wikidata.org/entity/Q35572430

about

Applications of nanotechnology in dermatology Stem Cell Tracking with Nanoparticles for Regenerative Medicine Purposes: An Overview Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine Biomedical applications of functionalized hollow mesoporous silica nanoparticles: focusing on molecular imaging Fluorescent imaging of cancerous tissues for targeted surgery.Hybrid nanoparticles for detection and treatment of cancer Immunotoxicity of silicon dioxide nanoparticles with different sizes and electrostatic charge Effect of silica and gold nanoparticles on macrophage proliferation, activation markers, cytokine production, and phagocytosis in vitro Convergence of nanotechnology and cancer prevention: are we there yet?Biocompatibility assessment of Si-based nano- and micro-particles Realizing the clinical potential of cancer nanotechnology by minimizing toxicologic and targeted delivery concerns Amine modification of nonporous silica nanoparticles reduces inflammatory response following intratracheal instillation in murine lungs Theranostic nanoparticles Integrated diagnostics: proceedings from the 9th biennial symposium of the International Society for Strategic Studies in Radiology Theranostic mesoporous silica nanoparticles biodegrade after pro-survival drug delivery and ultrasound/magnetic resonance imaging of stem cells.Dawn of advanced molecular medicine: nanotechnological advancements in cancer imaging and therapy.Surface modified multifunctional nanomedicines for simultaneous imaging and therapy of cancer.Commercial nanoparticles for stem cell labeling and tracking.Dynamic Positron Emission Tomography Imaging of Renal Clearable Gold Nanoparticles.Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth Development of 99mTc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer.State-of-the-art in design rules for drug delivery platforms: lessons learned from FDA-approved nanomedicines Quantitative characterization of fluorophores in multi-component nanoprobes by single-molecule fluorescence.PARPi-FL--a fluorescent PARP1 inhibitor for glioblastoma imaging Investigating the optimal size of anticancer nanomedicine.Positron emission tomography image-guided drug delivery: current status and future perspectives.VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.Theranostic nanoparticles carrying doxorubicin attenuate targeting ligand specific antibody responses following systemic delivery.Luminescent silica nanoparticles for cancer diagnosis Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery.Internalization and fate of silica nanoparticles in C2C12 skeletal muscle cells: evidence of a beneficial effect on myoblast fusion.Gold-silica quantum rattles for multimodal imaging and therapy In Vivo Tumor Vasculature Targeting of CuS@MSN Based Theranostic Nanomedicine.Ultrasmall integrin-targeted silica nanoparticles modulate signaling events and cellular processes in a concentration-dependent manner.Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe.Measurement of plasma volume using fluorescent silica-based nanoparticles.Aptamer-functionalized, ultra-small, monodisperse silica nanoconjugates for targeted dual-modal imaging of lymph nodes with metastatic tumors.Large-Scale Silica Overcoating of Gold Nanorods with Tunable Shell Thicknesses.Prophylactic effect of topical silica nanoparticles as a novel antineovascularization agent for inhibiting corneal neovascularization following chemical burn.Ligand-targeted theranostic nanomedicines against cancer

P2860

Q24170384-C2ECF81E-84A9-4629-9929-ECBD7942A6FE Q26770087-9AFFD9C3-F461-4593-BFAE-AE9387A36DE1 Q26770108-5C7D9FE3-5A05-49A3-B15A-65378C735AE2 Q26827998-F2AA56E2-8E7A-418B-B939-9B0DFB272AD7 Q26830905-F3EC723C-CFE8-4982-B8DE-E2A8FA564EEF Q26849404-95E400B9-59B0-492F-B463-6B3F693C3A0E Q28385227-5A77A4EF-CD00-4AD0-B0EB-4F63444C60C3 Q28385413-B96DBDF3-802B-4973-B85A-C71B87356C76 Q28386699-A2CED015-4E4E-4F18-BD47-40E8DE866404 Q28389467-666A4E2A-F1DB-494F-845B-C4FAE6CF43F7 Q28396462-3365590F-71DB-4DAF-AD90-BEA21A71E0C6 Q28397622-A0038B05-E325-40C1-9F81-BA1905C4B322 Q28650348-4A4A14FB-A9C4-4316-9F33-BD871A17BA13 Q28727036-2039ECFE-1869-46AE-ABCC-ED2DCCCAE118 Q30415766-0E8B13E2-4DEE-4DFC-A357-65B830C6E47F Q30421668-A8284D29-3F5E-43A5-9F3E-2C9F02A404CE Q30439353-3BA8871D-C0A0-4A38-9E4E-E95EC59DD19A Q30450859-8555229E-99DA-4DD0-A460-DB8A74C2D482 Q30759992-D550B64F-EFC7-4975-B7BF-F650ED987850 Q30828545-AAD424C3-A862-48A6-ACD3-C2F7F77C33A7 Q33649880-C56DEE0D-F23A-4368-B46C-CC9B0783DA57 Q34045119-A9DA5DA9-3C02-4A60-B49C-05CD769EE8CC Q34057232-0C0704AA-47A6-4E82-8AB8-8BF345E3E9E6 Q34346449-F142A8D1-6217-46B1-99CB-9294973C6C94 Q34442139-92129CDF-D33D-458F-87D2-69040B44BC52 Q34446108-094F9893-8D8E-4A5B-B7F6-CF390BEADCDD Q34674541-4290BCDE-C1DE-4697-887D-9F92D8C02178 Q34698633-82D7F110-D5FA-481D-9F8A-981C7C04EAA4 Q35024923-255A4763-96F3-48C5-BACF-D971D500CF2B Q35099618-F549033A-B7D3-4625-9DBE-12E920A75B85 Q35121191-7E7073FD-7EB5-404E-8DB9-8D634236ED65 Q35128741-8A9FF07F-C892-4501-8B63-84AFE688A151 Q35554806-31436768-33D7-4A5C-BF3C-4248B06AFA8C Q35562019-C8E9F86B-FDCB-4E41-9DEB-7497DB9DB8F1 Q35590083-9D4D59B5-4003-4248-82D2-B7462896EC31 Q35787478-A71BE91F-A9A2-45B8-8F8B-C354F68675D2 Q35800936-F1E8E150-AE4A-4862-BE7F-31BB21BB9879 Q35801380-CF589306-E1DF-4FED-9E79-7C63FD2E9472 Q35884453-350952CE-9ADA-4302-BF4C-05B5E49C86E2 Q35895637-1433A1D1-94F0-4D84-BD5E-0F7196D3C351

P2860

Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma.

http://www.wikidata.org/entity/Q35572430

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Multimodal silica nanoparticle ...... in a model of human melanoma.

@ast

Multimodal silica nanoparticle ...... in a model of human melanoma.

@en

type

label

Multimodal silica nanoparticle ...... in a model of human melanoma.

@ast

Multimodal silica nanoparticle ...... in a model of human melanoma.

@en

prefLabel

Multimodal silica nanoparticle ...... in a model of human melanoma.

@ast

Multimodal silica nanoparticle ...... in a model of human melanoma.

@en

P1433

Q35572430-23FEDDB0-6C8E-4C62-878C-F03CC9E3D518

P1476

Q35572430-275A30B1-4B16-4964-A353-6C0E646E58D8

P2093

Q35572430-026198B1-7F3C-4A37-B3FF-90EE0B17FA6C

Q35572430-0D4DB2C4-3FAC-4198-BE17-F3D8A1262089

Q35572430-29BBCA89-F997-4852-971D-C01CE8FE6695

Q35572430-3131594C-562D-4EF5-BB9E-041EAEC79CDD

Q35572430-4B542C00-5065-4737-8A44-2C8BB016946B

Q35572430-4E965081-6342-4C6E-AD83-307E0BD08701

Q35572430-5BBEFB91-727D-4341-BEBA-AB9A0704BD33

Q35572430-5CE9B1B8-2D52-42C0-8D1F-1F50709E1443

Q35572430-7DE4DD21-9D68-4E33-8EA8-84AB598596A6

Q35572430-932ED0BC-D6C4-4BEF-BA38-AF5A7370B68D

P2860

Q35572430-004A8144-D4E5-42E1-902A-B80DD0D8465A

Q35572430-037AB0AA-567E-4D61-8573-70546EEADD76

Q35572430-03F235DF-E348-4601-A861-F8F0B20626B9

Q35572430-0B041844-51D6-427C-8890-43C9060CC7B1

Q35572430-0F9991CE-23B6-44A2-B285-1B4378EF3223

Q35572430-11998FFF-0820-45A3-9F88-3F674960582A

Q35572430-15798895-8EF6-4600-8386-D090B4C120CE

Q35572430-1C9E36AB-5266-4501-8344-5E7A5A303D96

Q35572430-28980EA6-CA96-4A25-A23B-C31AF9EC923E

Q35572430-335960FB-A28D-4482-8F97-5F2DEFD65DDB

P304

Q35572430-54795EBA-3347-4187-9FA6-137CB39ABB21

P31

Q35572430-54E5D8B6-B4AD-42BF-A2F0-A5FF92647090

P356

Q35572430-CF7DAF5A-04E5-4325-8359-10086BE03F77

P407

Q35572430-924C900B-60C5-4AF1-8AD4-36E1F96C3FD2

P433

Q35572430-283F5822-94D5-4118-8FA7-AE032C82CA11

P478

Q35572430-ED045645-FC3C-4D1C-A008-3419E64C849D

P50

Q35572430-5AD6A40E-D70D-4D41-A895-CA1E9909AD87

P577

Q35572430-BA956F39-987F-4ED7-B8B5-4DEBC35613E5

P698

Q35572430-96176132-F665-4F24-8263-4A6E23673E25

P921

Q35572430-CC3D4667-BB17-4842-AF28-4C250572D2B8

P932

Q35572430-2327BA0B-388C-4BA5-BF5B-3B3CA70C9E2D

P356

P1433

Journal of Clinical Investigation

P1476

Multimodal silica nanoparticle ...... s in a model of human melanoma

@en

P2093

Andrew Burns

http://www.w3.org/2001/XMLSchema#string

David Schaer

http://www.w3.org/2001/XMLSchema#string

Elisa DeStanchina

http://www.w3.org/2001/XMLSchema#string

Erik Herz

http://www.w3.org/2001/XMLSchema#string

Hooisweng Ow

http://www.w3.org/2001/XMLSchema#string

Jedd Wolchok

http://www.w3.org/2001/XMLSchema#string

Michelle S Bradbury

http://www.w3.org/2001/XMLSchema#string

Miriam Benezra

http://www.w3.org/2001/XMLSchema#string

Pat B Zanzonico

http://www.w3.org/2001/XMLSchema#string

Srikant Iyer

http://www.w3.org/2001/XMLSchema#string

P2860

Imaging in the era of molecular oncology.

Renal clearance of quantum dots.

Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping

Nanotechnology and cancer.

Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping

Design considerations for tumour-targeted nanoparticles.

In vivo biodistribution and clearance studies using multimodal organically modified silica nanoparticles.

Engineered knottin peptides: a new class of agents for imaging integrin expression in living subjects.

Hybrid PET-optical imaging using targeted probes.

Small-animal PET of melanocortin 1 receptor expression using a 18F-labeled alpha-melanocyte-stimulating hormone analog

P304

2768-2780

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI45600

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Oula Penate Medina

P577

2011-06-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21670497

http://www.w3.org/2001/XMLSchema#string

P921

P932

3223837

http://www.w3.org/2001/XMLSchema#string